about
LHRH agonists for adjuvant therapy of early breast cancer in premenopausal womenThe development of an arm activity survey for breast cancer survivors using the Protection Motivation Theory.A phase I study of extended dosing with lomeguatrib with temozolomide in patients with advanced melanoma.Conquer fear: protocol of a randomised controlled trial of a psychological intervention to reduce fear of cancer recurrence.Progressive resistance training and stretching following surgery for breast cancer: study protocol for a randomised controlled trial.An update in breast cancer screening and management.Systematic review of LHRH agonists for the adjuvant treatment of early breast cancer.Prevention of aromatase inhibitor-induced bone loss with alendronate in postmenopausal women: The BATMAN TrialInvestigation of herb-drug interactions with ginkgo biloba in women receiving hormonal treatment for early breast cancer.O(6)-methylguanine-DNA methyltransferase depletion and DNA damage in patients with melanoma treated with temozolomide alone or with lomeguatribSystemic treatment of HER2-positive metastatic breast cancer: a systematic review.Systemic treatment of HER2+ metastatic breast cancer: clinical conundrums and future perspectives.Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape.Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape.Small HER2-Positive Breast Cancer: Should Size Affect Adjuvant Treatment?Psychological morbidity and stress but not social factors influence level of fear of cancer recurrence in young women with early breast cancer: results of a cross-sectional study.MicroRNA-Related DNA Repair/Cell-Cycle Genes Independently Associated With Relapse After Radiation Therapy for Early Breast Cancer.A phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma.Factors affecting the preoperative and postoperative extracellular fluid in the arm on the side of breast cancer: a cohort study.Transient swelling versus lymphoedema in the first year following surgery for breast cancer.Lymphedema following taxane-based chemotherapy in women with early breast cancer.Fear of cancer recurrence in young women with a history of early-stage breast cancer: a cross-sectional study of prevalence and association with health behaviours.Acupuncture for treatment of arthralgia secondary to aromatase inhibitor therapy in women with early breast cancer: pilot study.Patients' preferences for adjuvant chemotherapy in early breast cancer: what makes AC and CMF worthwhile now?Troponin I as a predictor for trastuzumab-related cardiotoxicity: current data do not provide mechanistic insights or allow for incorporation into clinical practice.Attentional bias and metacognitions in cancer survivors with high fear of cancer recurrence.Physical activity and fitness in women with metastatic breast cancer.Factors that affect intention to avoid strenuous arm activity after breast cancer surgery.Exploratory analysis of cardiac biomarkers in women with normal cardiac function receiving trastuzumab for breast cancer.Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancer.Segmental measurement of breast cancer-related arm lymphoedema using perometry and bioimpedance spectroscopy.Risk factors for lymphoedema in women with breast cancer: A large prospective cohort.Cell cycle marker expression in benign and malignant intraductal papillary lesions of the breast.Upper limb progressive resistance training and stretching exercises following surgery for early breast cancer: a randomized controlled trialPrevention of osteoporosis as a consequence of aromatase inhibitor therapy in postmenopausal women with early breast cancer: Rationale and design of a randomized controlled trialRandomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous MelanomaComparing patients’ and their partners’ preferences for adjuvant chemotherapy in early breast cancerPilot study evaluating the role of cardiac magnetic resonance imaging in monitoring adjuvant trastuzumab therapy for breast cancerPectoral stretching program for women undergoing radiotherapy for breast cancerQuality of life of women treated with radiotherapy for breast cancer
P50
Q24240015-40133618-28A9-4046-804D-CB55CE007614Q33284059-6E56C86F-BB9E-47D3-9510-EDD95EF8D4E1Q33384102-8B9830EB-F257-48E3-AE64-E5B1E050BCA5Q34036483-E0EA1948-CC72-4336-925E-D1226AFCC8D7Q35215272-C236386F-CC05-4561-9881-D6D629078AC3Q35874123-AC904AD7-B7BE-41C8-BB62-5D91157D9EACQ36146322-1B3F9B22-F649-471D-8028-6856B54A5601Q36491519-D3DD4EB2-86C8-454D-A142-D8F281101416Q36762928-57C61BB5-C33D-465F-9A04-577D3EEAD735Q37177925-DA7EAFA5-9885-4088-8FCB-DFA6256716FDQ38209463-6549634D-4B42-4B7C-B6A7-5CCB6D87A911Q38209464-12090474-93B3-4116-B767-45277D36175AQ38784116-5A7475F9-DA7D-4852-9886-28619F2C5974Q38784119-174351B1-9699-4536-AC52-86B85979D1DDQ39039820-2B110233-22B3-474B-B386-474FE122D092Q39349916-E8E65EED-04EC-41F6-85E7-77D23F567A47Q41115565-5063CFEF-3559-4BDB-908F-F413436A02A4Q42599978-8FC886AF-53E4-4E90-992F-FAF0BE9C6403Q43951905-D3AB1CEC-0401-4F5C-8CBA-410C86437A81Q43964129-F3374083-5627-46AE-8A66-A0A4B7B1D1EAQ44787811-7F526FD9-8427-4E39-A74F-F5733B0A49E0Q46038692-E1B10168-BB0D-4380-9D88-33C55468443AQ46637243-905D298F-DFA1-412F-AE87-69FCFA45DEF9Q46673536-A29DC95F-4CBB-4D21-BDAE-4207497C40E0Q46886729-8F13F1E8-53ED-4BCF-826A-8D811C08855BQ47824712-3E6478F0-9565-4A39-B4EC-11AC06786819Q48071798-EAA0B576-4035-4FA0-92B2-F69E0BE833BCQ48270516-B4ECD3A4-87A6-4847-9A75-764DA9CBC187Q48922603-17E7BFAF-AB18-463F-A791-6D66B2586F79Q50931016-4EA9CDBC-AA65-457F-9703-BC8B799ECB73Q53067736-09A36D78-35FA-4B3E-9EC2-4DD863F70100Q53098685-8250A5B2-1D11-4C39-BB1A-00695992E9B6Q53670197-4F22604C-D1A7-46AA-B017-F86F8C91F2DFQ57391056-1024AC6D-EB0D-4223-905D-131444638EB0Q57391073-0622FB96-B9C1-402E-A9BC-045F3307F97EQ57571972-0B7BB18E-29DA-440B-B7DA-341D86BBC8A5Q60679730-D1B3B1FA-B844-4286-8DBB-020ED7BB9355Q62582493-C98FD54B-D527-4374-8DA9-BFF722B9208AQ79401875-B114DD3C-0104-4E4A-BBE5-15AC7C22488FQ81312385-2F952529-8DDD-4412-9376-89F65098DEBA
P50
description
hulumtuese
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jane Beith
@ast
Jane Beith
@en
Jane Beith
@es
Jane Beith
@nl
Jane Beith
@sl
type
label
Jane Beith
@ast
Jane Beith
@en
Jane Beith
@es
Jane Beith
@nl
Jane Beith
@sl
prefLabel
Jane Beith
@ast
Jane Beith
@en
Jane Beith
@es
Jane Beith
@nl
Jane Beith
@sl
P108
P106
P1153
6603101919
P21
P31
P496
0000-0002-4946-2789